0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.69%
Revenue growth of 8.69% while 0259.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
27.08%
Gross profit growth of 27.08% while 0259.HK is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-3.63%
Negative EBIT growth while 0259.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-26.39%
Negative operating income growth while 0259.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
3008.70%
Net income growth of 3008.70% while 0259.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
2827.27%
EPS growth of 2827.27% while 0259.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
2827.27%
Diluted EPS growth of 2827.27% while 0259.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
3.02%
Share change of 3.02% while 0259.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.02%
Diluted share change of 3.02% while 0259.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-52.42%
Dividend reduction while 0259.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
2536.42%
OCF growth of 2536.42% while 0259.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
1701.27%
FCF growth of 1701.27% while 0259.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
53271.44%
10Y revenue/share CAGR above 1.5x 0259.HK's 148.15%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
189.85%
5Y revenue/share CAGR above 1.5x 0259.HK's 67.75%. David Dodd would look for consistent product or market expansions fueling outperformance.
-15.26%
Negative 3Y CAGR while 0259.HK stands at 468.19%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
5898.47%
10Y OCF/share CAGR above 1.5x 0259.HK's 115.25%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
2081.08%
5Y OCF/share CAGR above 1.5x 0259.HK's 31.20%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
604.15%
3Y OCF/share CAGR above 1.5x 0259.HK's 131.04%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
300.18%
Net income/share CAGR above 1.5x 0259.HK's 76.77% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-7.74%
Negative 5Y net income/share CAGR while 0259.HK is 277.87%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-35.85%
Negative 3Y CAGR while 0259.HK is 111.88%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
245.28%
Equity/share CAGR of 245.28% while 0259.HK is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-97.11%
Negative near-term dividend growth while 0259.HK invests at 150.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-100.00%
Firm’s AR is declining while 0259.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.95%
Inventory shrinking or stable vs. 0259.HK's 37.28%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
23.69%
Asset growth above 1.5x 0259.HK's 4.96%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.08%
We have a declining book value while 0259.HK shows 1.19%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-35.87%
We’re deleveraging while 0259.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
34.88%
SG&A growth of 34.88% while 0259.HK is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.